| Patent | Date |
|---|
Antibodies To Oxidation-specific Epitopes
App 20220135704 - Tsimikas; Sotirios ; et al. | 2022-05-05 |
Compositions And Methods For Diagnosis Of Cardiovascular Disease
App 20210388116 - Miller; Yury ; et al. | 2021-12-16 |
Antibodies to oxidation-specific epitopes
Grant 11,168,148 - Tsimikas , et al. November 9, 2 | 2021-11-09 |
Inhibition Of Oxidation-specific Epitopes To Treat Ischemic Reperfusion Injury
App 20210221916 - Tsimikas; Sotirios ; et al. | 2021-07-22 |
Therapies And Methods To Treat Tlr2-mediated Diseases And Disorders
App 20210155679 - Witztum; Joseph L. ; et al. | 2021-05-27 |
Antibodies to oxidized phospholipids
Grant 11,008,382 - Witztum , et al. May 18, 2 | 2021-05-18 |
Antibodies to oxidized phospholipids
Grant 11,008,381 - Witztum , et al. May 18, 2 | 2021-05-18 |
Antibodies To Oxidation-specific Epitopes
App 20190225709 - Tsimikas; Sotirios ; et al. | 2019-07-25 |
Antibodies To Oxidized Phospholipids
App 20180334497 - Witztum; Joseph L. ; et al. | 2018-11-22 |
Antibodies To Oxidized Phospholipids
App 20180334498 - Witztum; Joseph L. ; et al. | 2018-11-22 |
Antibodies To Oxidized Phospholipids
App 20180265576 - Witztum; Joseph L. ; et al. | 2018-09-20 |
Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)
Grant 9,347,959 - Tsimikas , et al. May 24, 2 | 2016-05-24 |
Antibodies To Oxidized Phospholipids
App 20150376268 - Witztum; Joseph L. ; et al. | 2015-12-31 |
Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
Grant 9,075,050 - Tsimikas , et al. July 7, 2 | 2015-07-07 |
Oxidative Biomarkers In Predicting Risk Of Stroke, Transient Ischemic Attack (tia) And Peripheral Arterial Disease (pad)
App 20150185239 - Tsimikas; Sotirios ; et al. | 2015-07-02 |
Combination Of Spla2 Activity And Lp(a) Cardiovascular Risk Factors For The Diagnosis/prognosis Of A Cardiovascular Disease/event
App 20150132771 - Mallat; Ziad ; et al. | 2015-05-14 |
Peptide Mimotopes To Oxidation Specific Epitopes
App 20150056209 - Witztum; Joseph L. ; et al. | 2015-02-26 |
Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk
Grant 8,883,428 - Witztum , et al. November 11, 2 | 2014-11-11 |
Methods For Assessing Atherogenesis By Determining Oxidized Phospholipid To Apolipoprotein B Ratios
App 20140309124 - Tsimikas; Sotirios ; et al. | 2014-10-16 |
Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
Grant 8,383,355 - Mallat , et al. February 26, 2 | 2013-02-26 |
Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
Grant 8,361,732 - Mallat , et al. January 29, 2 | 2013-01-29 |
COMBINATION OF sPLA2 TYPE IIA MASS AND OXPL/APOB CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT
App 20130017557 - Mallat; Ziad ; et al. | 2013-01-17 |
Combination Of Spla2 Activity And Lp(a) Cardiovascular Risk Factors For The Diagnosis/prognosis Of A Cardiovascular Disease/event
App 20120264146 - Mallat; Ziad ; et al. | 2012-10-18 |
Combination Of Spla2 Activity And Oxpl/apob Cardiovascular Risk Factors For The Diagnosis/prognosis Of A Cardiovascular Disease/event
App 20120171705 - Mallat; Ziad ; et al. | 2012-07-05 |
Methods For Assessing Atherogenesis By Determining Oxidized Phospholipid To Apolipoprotein B Ratios
App 20120149596 - Tsimikas; Sotirios ; et al. | 2012-06-14 |
Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
Grant 8,163,504 - Mallat , et al. April 24, 2 | 2012-04-24 |
Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
Grant 8,129,123 - Tsimikas , et al. March 6, 2 | 2012-03-06 |
Methods To Determine Atherosclerosis Regression, Plaque Stabiliztion And Cardiovascular Risk
App 20120035074 - Witztum; Joseph L. ; et al. | 2012-02-09 |
Combination Of Spla2 Activity And Oxpl/apob Cardiovascular Risk Factors For The Diagnosis/prognosis Of A Cardiovascular Disease/event.
App 20110229919 - Mallat; Ziad ; et al. | 2011-09-22 |
Methods of identifying a subject having or at risk of having or developing coronary artery disease
Grant 7,939,287 - Tsimikas , et al. May 10, 2 | 2011-05-10 |
Method and Materials for Use in Diagnosing Viral Myocarditis
App 20110097272 - Knowlton; Kirk ; et al. | 2011-04-28 |
Method and materials for use in diagnosing viral myocarditis
Grant 7,867,476 - Knowlton , et al. January 11, 2 | 2011-01-11 |
PHOSPHOLIPID OXIDATION AND Lp-PLA2 AS PREDICTORS OF CORONARY ARTERY DISEASE
App 20090317819 - Tsimikas; Sotirios ; et al. | 2009-12-24 |
Reagents for diagnosing, imaging and treating atherosclerotic disease
Grant 7,575,873 - Witztum , et al. August 18, 2 | 2009-08-18 |
Methods for diagnosing, imaging and treating atherosclerotic disease
Grant 7,556,927 - Witztum , et al. July 7, 2 | 2009-07-07 |
Method and Materials for Use in Diagnosing Viral Myocarditis
App 20070292345 - Khowlton; Kirk ; et al. | 2007-12-20 |
Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
App 20060177435 - Tsimikas; Sotirios ; et al. | 2006-08-10 |
Reagents for diagnosing, imaging and treating atherosclerotic disease
App 20040120893 - Witztum, Joseph L. ; et al. | 2004-06-24 |
Methods for diagnosing, imaging and treating atherosclerotic disease
App 20040071632 - Witztum, Joseph L. ; et al. | 2004-04-15 |
Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
Grant 6,716,410 - Witztum , et al. April 6, 2 | 2004-04-06 |
| 